Beyond ctDNA: Tracking the Evolution of the Cancer Biomarker...

Ajouter une nouvelle offre d'emploi Health

2025-11-21 07:27:48 -

Beyond ctDNA: Tracking the Evolution of the Cancer Biomarker Testing Outlook

The utility of liquid biopsy extends well beyond circulating tumor DNA, encompassing a dynamic range of biomarkers that provide complementary insights into cancer biology. The overall outlook for cancer biomarker testing is incredibly positive, driven by the need for multi-dimensional information covering genetic, epigenetic, and proteomic changes associated with tumor growth and metastasis....

0 Commentaires 0 Parts 400 Vue 0 Aperçu